(Q34600416)

3 August 2017

1 reference

title

Age-related maculopathy: pathogenetic features and new treatment modalities (English)

1 reference

3 August 2017

0 references

2

Stefan Seregard

1 reference

3 August 2017

Peep V Algvere

1

1 reference

3 August 2017

publication date

1 April 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

80

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

136-143

1 reference

Transpupillary thermotherapy of occult CNV with no or minimally classic CNV in age-related macular degeneration

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): a study with radioactively labelled microspheres including flow determinations in brain and some other tissues

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Macular translocation: unifying concepts, terminology, and classification

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

The role of oxidative stress in the pathogenesis of age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Basal linear deposit and large drusen are specific for early age-related maculopathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Limited macular translocation for neovascular maculopathy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Apoptosis in surgically excised choroidal neovascular membranes in age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Rod outer segments mediate mitochondrial DNA damage and apoptosis in human retinal pigment epithelium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Fas ligand (CD95 ligand) controls angiogenesis beneath the retina

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Prevalence and visual consequences of macular changes in a population aged 70 years and older

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Risk factors for age-related maculopathy: the Visual Impairment Project

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Upregulation of pigment epithelium-derived factor after laser photocoagulation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Aging changes in Bruch's membrane. A histochemical and morphologic study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Radiation Therapy for Age-related Macular Degeneration

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Morphology of early choroidal neovascularisation in age-related macular degeneration: correlation with activity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Risk factors for age-related macular degeneration: Pooled findings from three continents.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Lipofuscin-formation in cultured retinal pigment epithelial cells is related to their melanin content

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Transplantation of autologous iris pigment epithelium after removal of choroidal neovascular membranes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

The prevalence of age-related maculopathy: the visual impairment project

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

The prevalence of age-related maculopathy in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

Blue light induced apoptosis in rat retina

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0420.2002.800204.X

7 January 2021

10.1034/J.1600-0420.2002.800204.X

Identifiers

DOI

1 reference

3 August 2017

1 reference